More Than One Fourth Of US Adults Reported Feeling Symptoms Of Depression In The Early Months Of The Pandemic: Report

US News & World Report (2/4, Cirruzzo) reports, “More than a quarter of U.S. adults who participated in an online survey given in the early months of the COVID-19 pandemic were experiencing symptoms of current depression, a new report (2/4) from the Centers for Disease Control and Prevention shows, with the prevalence of mental distress highest among Hispanics.” Estimates “based on an opt-in online survey of adults 18 and over last year show that 28.6% of respondents were suffering from current depression, 18.2% had initiated or increased substance use, and 8.4% were having suicidal thoughts.” The survey “was conducted in April and May of 2020, with results based on 1,004 respondents.”

Related Links:

— “Hispanics See High Prevalence of Depression, Food Worries During COVID-19 “Chelsea Cirruzzo, US News & World Report, February 4, 2021

COVID-19 Pandemic Appears To Have Shifted ED Use, Priorities For Care, Particularly Related To Mental Health, Study Suggests

Healio (2/4, Gramigna) reports, “The COVID-19 pandemic appeared to shift ED use and priorities for care, particularly related to mental health, substance use and violence risk screening and prevention,” researchers concluded after capturing data on “187,508,065 ED visits, of which 6,018,318 included at least one study outcome, between December 30, 2018, and October 10, 2020.” After comparing “the median ED visit counts between March 15, 2020, and October 10, 2020, with the same period in 2019,” the study team “found that the 2020 counts were significantly higher for suicide attempts, all overdoses and opioid overdoses.” The findings were published online Feb. 3 in JAMA Psychiatry.

Related Links:

— “COVID-19 pandemic has shifted ED use related to mental health, substance use, violence “Joe Gramigna, Healio, February 4, 2021

McKinsey agrees to $573M settlement with states over role in opioid crisis

The New York Times (2/3, A1, Forsythe, Bogdanich) reports, “McKinsey & Company, the consultant to blue-chip corporations and governments around the world, has agreed to pay $573 million to settle investigations into its role in helping ‘turbocharge’ opioid sales, a rare instance of it being held publicly accountable for its work with clients.” The firm “has reached the agreement with attorneys general in 47 states, the District of Columbia and five territories, according to five people familiar with the negotiations.” The settlement “comes after lawsuits unearthed a trove of documents showing how McKinsey worked to drive sales of Purdue Pharma’s OxyContin” pain medication “amid an opioid epidemic in the United States that has contributed to the deaths of more than 450,000 people over the past two decades.”

Related Links:

— “McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis ” Michael Forsythe and Walt Bogdanich, The New York Times, February 3, 2021

Percentage Of Fatal Overdose Cases In Philadelphia With Detectable Levels Of Xylazine Rose From 2% To 31% During A Ten-Year Period, Researchers Say

Healio (2/3, Miller) reports, “The percentage of fatal overdose cases in Philadelphia with detectable levels of xylazine rose from 2% to 31% during a 10-year period, suggesting that the United States’ opioid epidemic ‘continues to evolve,’” investigators concluded after analyzing “data on overdose deaths from heroin, fentanyl or both from the Philadelphia Medical Examiner’s Office.” The findings were published online in the journal Injury Prevention.

Related Links:

— “Xylazine found in one-third of fatal opioid overdoses in Philadelphia “Janel Miller, Healio, February 3, 2021

Documents Reveal Finasteride May Cause Suicidal Thoughts, Behavior In Men

Reuters (2/3, Terhune, Levine) reports, “Newly unsealed court documents and other records show that Merck & Co and U.S. regulators knew about reports of suicidal behavior in men taking the company’s anti-baldness treatment Propecia [finasteride] when they decided not to warn consumers of those potential risks in a 2011” label update of the medication. In late January, “internal records from Merck were made public…when a federal magistrate in Brooklyn, New York, granted a 2019 Reuters motion to unseal 11 documents filed in years of litigation alleging Propecia caused persistent sexual dysfunction and other harmful side effects.” Following “the 2011 decision on the warning, the FDA has received more than 700 reports of suicide and suicidal thoughts among people taking Propecia or generic versions of the drug.”

Related Links:

— “Exclusive: Merck anti-baldness drug Propecia has long trail of suicide reports, records show ” Dan Levine, Chad Terhune, Reuters, February 3, 2021

Study indicates 34% of young adults misuse psychoactive drugs

CNN (2/2, Marples) reports a study by the Harvard School of Dental Medicine found “34% of adults ages 18 to 25 misused their psychoactive medications,” which include “opioids, stimulants, tranquilizers and sedatives.” The analysis of “surveys of U.S. youth and young adults taken between 2015 and 2018” also found “over 20% of youth ages 12 to 17 who took psychoactive medications were also found to be misusing these drugs.” The findings were published Tuesday in the British Medical Journal.

Related Links:

— “Over one-third of young adults misuse psychoactive medications, study says “Megan Marples, Megan Marples, February 2, 2021

Cannabis Use Disorder May Be Tied To Self-Harm, All-Cause Mortality, Unintentional Overdose Death And Homicide Among Youth With Mood Disorders, Data Indicate

Healio (2/2, Downey) reports, “Cannabis use disorder was associated with self-harm, all-cause mortality, unintentional overdose death and homicide among youth with mood disorders,” investigators concluded after examining data on “204,780 youths aged between 10 and 24 years with a diagnosis of a mood disorder between July 1, 2010, and Dec. 31, 2017.” The findings were published online Jan. 19 in JAMA Pediatrics.

Related Links:

— “Cannabis use disorder a risk marker for self-harm among youths with mood disorders “Ken Downey Jr., Healio, February 2, 2021

Pandemic Has Created Perfect Storm Of Stressors For Kids, Physicians Say

NPR (2/2, Chatterjee) reports, “An abrupt spike in suicide deaths among students in the Clark County School District has officials in the Las Vegas district wondering if pressures brought on by the coronavirus pandemic might have been part of what fueled” that rise. NPR talked to medical professionals “at hospitals in seven states across the country, and all of them reported a similar trend: More suicidal children are coming to their hospitals – in worse mental states.” Meanwhile, psychiatrists and other physicians “who work with children say the pandemic has created a perfect storm of stressors for kids,” exacerbating “an ongoing children’s mental health crisis.”

Related Links:

— “Child Psychiatrists Warn That The Pandemic May Be Driving Up Kids’ Suicide Risk “Rhitu Chatterjee, NPR, February 2, 2021

College Football Players May Sustain Far More Concussions During Practices Than In Games, Research Suggests

The New York Times (2/1, Blinder) reports, “College football players sustained far more concussions during practices than they did in games,” research indicates.

MedPage Today (2/1, George) reports, “College football players were more likely to have concussions and head hits during practices and preseason training rather than regular season play,” investigators concluded in “an observational study of National Collegiate Athletic Association…Division I players.” The study revealed that “in six NCAA teams across five pre-pandemic seasons, 72% of concussions and 67% of head impacts occurred during practices,” and “roughly half of all concussions occurred during preseason training, even though preseason training represented just 21% of the whole season.” The findings were published online in a brief report in JAMA Neurology.

Related Links:

— “Football Practices Pose More Concussion Risk Than Games, Study Suggests “Alan Blinder, The New York Times, February 1, 2021

President Biden Faces Criticism Over His Handling Of The Opioid Epidemic

NPR (1/29, Mann) reported President Biden is facing criticism for his handling of the ongoing opioid epidemic, which has received less attention during the COVID-19 pandemic. Some critics have pointed to his decision to delay guidelines that would have eased access to buprenorphine as a misstep.

Related Links:

— “With Biden Team Focused On Other Crises, Experts Say Drug Epidemic Is Exploding “Brian Mann , NPR, January 29, 2021